Milestone Reached: First Patient Dosed in Phase 3 Trial of Innovative Blood Cancer Therapy
A significant milestone has been achieved in the fight against blood cancers, as the first patient has been dosed in a pivotal Phase 3 clinical
Cancer Commons
Cancer Commons
When you have cancer, navigating care can be overwhelming. You may wonder whether you’re on the right path, or if you’re missing out on promising new treatments.
Cancer Commons can help. Our nurse navigators, patient support specialists, PhD scientists, and nationally-recognized oncology experts combine compassion with deep scientific knowledge to help you understand your disease and access your best treatment options.
We draw on the most up-to-date research—as well as insights from leading cancer experts, and outcomes from patients on treatments beyond the standard of care—so you can be confident you’ve left no stone unturned.
Personalized Action Plans
Depending on your needs, we can help:
- Locate clinical trials that may provide access to leading-edge treatments
- Identify and access promising off-label treatments
- Find and access treatments that are available through expanded access or compassionate use
- Identify molecular diagnostic testing to guide treatment
- Explain treatments and tests in plain language
- Make sense of multiple treatment recommendations
- Keep you updated on the latest developments in cancer research
Condition Awareness & Advocacy
Here is a list of conditions this partner raises awareness and advocacy for:
Patient Worthy Posts on Cancer
Anixa Biosciences Advances CAR-T Therapy: First Patient Dosed in Fourth Clinical Trial Cohort
Anixa Biosciences has reached a new milestone in the development of its innovative CAR-T cell therapy, announcing the dosing of the first patient in the
A Case for Full Disclosure: Two Drugs, Two Women, Only One Survived
Sixty-five-year-old JoEllen Zembruski-Ruple had been a cancer patient at the revered Sloan Kettering center in January of this year. Her treatment for squamous cell carcinoma
Patient Worthy Launches Cancer-Focused Companion Site WHATNEXT.com
The team at Patient Worthy is excited to announce the official launch of our collaboration with our companion site WHATNEXT.com, a cancer-focused online community and
Research Breakthrough: Scientists May Have Discovered How Tumor Cells Outwit the Immune System
Editor’s Note: Chronic conditions and rare diseases don’t discriminate, Patient Worthy and its partners are interested in amplifying the voices of those from all identities
Oncologist at MD Anderson Gives Advice to Patients Undergoing Chemotherapy
In 2023, there have been new drug approvals and increased patient awareness. The American Cancer Society reported a total of 1,958,310 new cancer cases in
